192 related articles for article (PubMed ID: 38316788)
1. Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche.
Dawson A; Zarou MM; Prasad B; Bittencourt-Silvestre J; Zerbst D; Himonas E; Hsieh YC; van Loon I; Blanco GR; Ianniciello A; Kerekes Z; Krishnan V; Agarwal P; Almasoudi H; McCluskey L; Hopcroft LEM; Scott MT; Baquero P; Dunn K; Vetrie D; Copland M; Bhatia R; Coffelt SB; Tiong OS; Wheadon H; Zanivan S; Kirschner K; Helgason GV
Nat Commun; 2024 Feb; 15(1):1090. PubMed ID: 38316788
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
[TBL] [Abstract][Full Text] [Related]
3. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Busch C; Mulholland T; Zagnoni M; Dalby M; Berry C; Wheadon H
Cell Commun Signal; 2023 Nov; 21(1):342. PubMed ID: 38031192
[TBL] [Abstract][Full Text] [Related]
4. Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model.
Langhammer M; Schöpf J; Jaquet T; Horn K; Angel M; Spohr C; Christen D; Uhl FM; Maié T; Jacobi H; Feyerabend TB; Huber J; Panning M; Sitaru C; Costa I; Zeiser R; Aumann K; Becker H; Braunschweig T; Koschmieder S; Shoumariyeh K; Huber M; Schemionek-Reinders M; Brummer T; Halbach S
Leukemia; 2023 Jul; 37(7):1474-1484. PubMed ID: 37161070
[TBL] [Abstract][Full Text] [Related]
5. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract][Full Text] [Related]
6. CML Mouse Model Generated from Leukemia Stem Cells.
Hu Y
Methods Mol Biol; 2016; 1465():27-35. PubMed ID: 27581136
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
[TBL] [Abstract][Full Text] [Related]
8. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
9. Morgana acts as an oncosuppressor in chronic myeloid leukemia.
Di Savino A; Panuzzo C; Rocca S; Familiari U; Piazza R; Crivellaro S; Carrà G; Ferretti R; Fusella F; Giugliano E; Camporeale A; Franco I; Miniscalco B; Cutrin JC; Turco E; Silengo L; Hirsch E; Rege-Cambrin G; Gambacorti-Passerini C; Pandolfi PP; Papotti M; Saglio G; Tarone G; Morotti A; Brancaccio M
Blood; 2015 Apr; 125(14):2245-53. PubMed ID: 25678499
[TBL] [Abstract][Full Text] [Related]
10. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
Drexler HG; MacLeod RA; Uphoff CC
Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
[TBL] [Abstract][Full Text] [Related]
11. [Effect of gemcitabine on granulocyte colony-stimulating factor receptor and bcr/abl mRNA in patients with chronic myeloid leukemia].
Liu D; Wang F; Sun L; Liu LX; Liu YF; Ling Z; Han XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1168-71. PubMed ID: 21129254
[TBL] [Abstract][Full Text] [Related]
12. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.
Sirard C; Lapidot T; Vormoor J; Cashman JD; Doedens M; Murdoch B; Jamal N; Messner H; Addey L; Minden M; Laraya P; Keating A; Eaves A; Lansdorp PM; Eaves CJ; Dick JE
Blood; 1996 Feb; 87(4):1539-48. PubMed ID: 8608245
[TBL] [Abstract][Full Text] [Related]
13. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
[TBL] [Abstract][Full Text] [Related]
14. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
[TBL] [Abstract][Full Text] [Related]
15. Detection of the bcr/abl gene in bone marrow macrophages in CML and alterations during interferon therapy--a fluorescence in situ hybridization study on trephine biopsies.
Thiele J; Schmitz B; Fuchs R; Kvasnicka HM; Lorenzen J; Fischer R
J Pathol; 1998 Nov; 186(3):331-5. PubMed ID: 10211125
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the proportion of Philadelphia chromosome-positive metaphase cells and levels of BCR-ABL mRNA in chronic myeloid leukaemia.
Lin F; Chase A; Bungey J; Goldman JM; Cross NC
Genes Chromosomes Cancer; 1995 Jun; 13(2):110-4. PubMed ID: 7542905
[TBL] [Abstract][Full Text] [Related]
17. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia.
Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA
Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580
[TBL] [Abstract][Full Text] [Related]
18. Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche.
Krause DS; Lazarides K; Lewis JB; von Andrian UH; Van Etten RA
Blood; 2014 Feb; 123(9):1361-71. PubMed ID: 24394666
[TBL] [Abstract][Full Text] [Related]
19. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
[TBL] [Abstract][Full Text] [Related]
20. Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia.
Greiner G; Ratzinger F; Gurbisz M; Witzeneder N; Taghizadeh H; Mustafa SGK; Mitterbauer-Hohendanner G; Esterbauer H; Mannhalter C; Sperr WR; Valent P; Hoermann G
Clin Chem Lab Med; 2020 Jul; 58(8):1214-1222. PubMed ID: 32084002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
